Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter P. Roller is active.

Publication


Featured researches published by Peter P. Roller.


Journal of Medicinal Chemistry | 2004

Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.

Zaneta Nikolovska-Coleska; Liang Xu; Zengjian Hu; York Tomita; Peng Li; Peter P. Roller; Renxiao Wang; Xueliang Fang; Ribo Guo; Manchao Zhang; Marc E. Lippman; Dajun Yang; Shaomeng Wang

The X-linked inhibitor of apoptosis (XIAP) is a promising new molecular target for the design of novel anticancer drugs aiming at overcoming apoptosis-resistance of cancer cells to chemotherapeutic agents and radiation therapy. Recent studies demonstrated that the BIR3 domain of XIAP where caspase-9 and Smac proteins bind is an attractive site for designing small-molecule inhibitors of XIAP. Through computational structure-based screening of an in-house traditional herbal medicine three-dimensional structure database of 8221 individual natural products, followed by biochemical testing of selected candidate compounds, we discovered embelin from the Japanese Ardisia herb as a small-molecular weight inhibitor that binds to the XIAP BIR3 domain. We showed that embelin binds to the XIAP BIR3 protein with an affinity similar to that of the natural Smac peptide using a fluorescence polarization-based binding assay. Our NMR analysis further conclusively confirmed that embelin interacts with several crucial residues in the XIAP BIR3 domain with which Smac and caspsase-9 bind. Embelin inhibits cell growth, induces apoptosis, and activates caspase-9 in prostate cancer cells with high levels of XIAP, but has a minimal effect on normal prostate epithelial and fibroblast cells with low levels of XIAP. In stably XIAP-transfected Jurkat cells, embelin effectively overcomes the protective effect of XIAP to apoptosis and enhances the etoposide-induced apoptosis and has a minimal effect in Jurkat cells transfected with vector control. Taken together, our results showed that embelin is a fairly potent, nonpeptidic, cell-permeable, small-molecule inhibitor of XIAP and represents a promising lead compound for designing an entirely new class of anticancer agents that target the BIR3 domain of XIAP.


Biochemical Pharmacology | 2003

Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells.

Manchao Zhang; Hongpeng Liu; Ribo Guo; Yan Ling; Xiaojin Wu; Bihua Li; Peter P. Roller; Shaomeng Wang; Dajun Yang

Gossypol, a male contraceptive drug, has been demonstrated to have antiproliferative and antimetastatic effects on many kinds of cancer cells in vitro. HT-29 human carcinoma cell line is one of the most susceptible cell lines to gossypol-induced cell death. Here, it is shown that treatment of HT-29 cells with gossypol not only induces cell cycle arrest on the G0/G1 phase, but also induces apoptosis. With a serial of Western blot analysis, it is revealed that gossypol-induced cell cycle arrest is involved in P21 up-regulation and cyclin D1 down-regulation; gossypol-induced apoptosis triggers down-regulation of anti-apoptosis Bcl-2 members: Bcl-X(L), Bag-1 and Mcl-1, up-regulation of pro-apoptosis Bcl-2 member Bak, activation of caspase-3, -6, -7, -8, and -9, up-regulation of Apaf-1, release of cytochrome c (cyto-c) from mitochondria, and activation of both DFF45 and PARP. Taken together, gossypol-induced cell death initiates extensive alterations of cell cycle and apoptosis proteins. Gossypol-induced apoptosis of HT-29 cells is through first the mitochondrial pathway, then the death receptor pathway, and the mitochondria pathway is, at least in part, involved in cyto-c release.


Journal of Biological Chemistry | 1997

Nonphosphorylated Peptide Ligands for the Grb2 Src Homology 2 Domain

Lyn Oligino; Feng-Di T. Lung; L. Sastry; J. Bigelow; T. Cao; M. Curran; Terrence R. Burke; Shaomeng Wang; David N. Krag; Peter P. Roller; C. R. King

Critical intracellular signals in normal and malignant cells are transmitted by the adaptor protein Grb2 by means of its Src homology 2 (SH2) domain, which binds to phosphotyrosyl (pTyr) residues generated by the activation of tyrosine kinases. To understand this important control point and to design inhibitors, previous investigations have focused on the molecular mechanisms by which the Grb2 SH2 domain selectively binds pTyr containing peptides. In the current study, we demonstrate that the Grb2 SH2 domain can also bind in a pTyr independent manner. Using phage display, an 11-amino acid cyclic peptide, G1, has been identified that binds to the Grb2 SH2 domain but not the src SH2 domain. Synthetic G1 peptide blocks Grb2 SH2 domain association (IC50 10–25 μm) with a 9-amino acid pTyr-containing peptide derived from the SHC protein (pTyr317). These data and amino acid substitution analysis indicate that G1 interacts in the phosphopeptide binding site. G1 peptide requires a YXN sequence similar to that found in natural pTyr-containing ligands, and phosphorylation of the tyrosine increases G1 inhibitory activity. G1 also requires an internal disulfide bond to maintain the active binding conformation. Since the G1 peptide does not contain pTyr, it defines a new type of SH2 domain binding motif that may advance the design of Grb2 antagonists.


Journal of Biological Chemistry | 2001

Oligomerization of Human Gadd45a Protein

Oleg Kovalsky; Feng-Di T. Lung; Peter P. Roller; Albert J. Fornace

Gadd45a is an 18-kDa acidic protein that is induced by genotoxic and certain other cellular stresses. The exact function of this protein is not known. However, there is evidence for its involvement in growth control, maintenance of genomic stability, DNA repair, cell cycle control, and apoptosis. Consistently, Gadd45a has previously been shown to interact in vitro and/orin vivo with a number of proteins playing central roles in these cellular processes: proliferating cell nuclear antigen, p21Cip1/Waf1, Cdc2-CyclinB complex, MTK1, and histones. Adding to this complexity, we have found that Gadd45a self-associates in solution, both in vitro and when expressed in the cell. Moreover, Gadd45a can complex with the two other members of the Gadd45 family of stress-induced proteins, human Gadd45b (MyD118) and Gadd45g (CR6). Gel-exclusion chromatography, native gel electrophoretic analysis, enzyme-linked immunosorbent assay, and chemical cross-linking showed that recombinant Gadd45a forms dimeric, trimeric, and tetrameric species in vitro, the dimers being the predominant form. Deletion mutant and peptide scanning analyses suggest that Gadd45a has two self-association sites: within N-terminal amino acids 33–61 and within 40 C-terminal amino acids. Despite the low abundance of Gadd45a in the cell, oligomer-forming concentrations can probably be achieved in the foci-like nuclear structures formed by the protein upon overexpression. Evidence for a potential role of Gadd45a self-association in altering DNA accessibility on damaged nucleosomes is presented.


Tetrahedron Letters | 1993

Synthesis of 4-phosphono(difluoromethyl)-D,L-phenylalanine and N-boc and N-Fmoc derivatives suitably protected for solid-phase synthesis of nonhydrolyzable phosphotyrosyl peptide analogues

Terrence R. Burke; Mark S. Smyth; Akira Otaka; Peter P. Roller

Abstract Synthesis of 4-phosphono(difluoromethyl)-D,L-phenylalanine as well as its diethyl phosphonate analogues bearing either Boc or Fmoc-amino protection are reported. The latter two derivatives were utilized for the solid-phase synthesis of SH2-related peptides containing nonhydrolyzable phosphotyrosyl mimetics.


Nucleic Acids Research | 2006

Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites

Christophe Marchand; Krzysztof Krajewski; Hsiu-Fang Lee; Smitha Antony; Allison A. Johnson; Ronak Amin; Peter P. Roller; Mamuka Kvaratskhelia; Yves Pommier

Indolicidin is a host defense tridecapeptide that inhibits the catalytic activity of HIV-1 integrase in vitro. Here we have elucidated its mechanism of integrase inhibition. Using crosslinking and mass spectrometric footprinting approaches, we found that indolicidin interferes with formation of the catalytic integrase-DNA complex by directly binding DNA. Further characterization revealed that the peptide forms covalent links with abasic sites. Indolicidin crosslinks single- or double-stranded DNAs and various positions of the viral cDNA with comparable efficiency. Using truncated and chemically modified peptides, we show that abasic site crosslinking is independent of the PWWP motif but involves the indolicidin unique lysine residue and the N- and C- terminal NH2 groups. Because indolicidin can also inhibit topoisomerase I, we believe that multiple actions at the level of DNA might be a common property of antimicrobial peptides.


Biochemical Pharmacology | 1981

Dose-dependent kinetics of all-trams-retinoic acid in rats: Plasma levels and excretion into bile, urine, and faeces

Brian N. Swanson; Charles A. Frolik; Daniel W. Zaharevitz; Peter P. Roller; Michael B. Sporn

Abstract Plasma concentration-time curves for all-trans-retinoic acid (RA) after 0.015.0.25 or 5 mg/kg, i.V., deviated from first-order kinetics in the rat. Within 10 min after the i.v. infusion, a rapid, dose-dependent decrease in RA concentration was observed (slope steepest at the lowest dose). During a secondary phase of slower decline, the times required to halve the RA concentration after 0.015, 0.25 and 5 mg/kg were 40, 65 and 120 min respectively. At later times, the concentration-time curves for all three dose levels assumed a fast rate of decline (half-life about 19 min at the lower dose). The dose-dependent kinetics of RA in plasma were not due to enterohepatic recirculation of RA, since RA levels in plasma were not lower in rats with biliary fistulas given comparable doses. In contrast, circulating levels of RA metabolites remained elevated for several hours and were significantly diminished by interruption of the enterohepatic circulation. After a dose of [10-3H]RA, the rate of biliary excretion of radiolabeled material was initially slower after 5 mg/kg RA than after 0.015 mg/kg RA. Within the first 24 hr, however, approximately the same proportion of both doses appeared in bile. All-trans-retinoyl-β-glucuronide is only a minor biliary metabolite of RA. Glucuronidation of RA was dose-dependent, since the percentage of total biliary metabolites represented by all-trans-retinoyl-β-glucuronide increased with increasing dose. Renal excretion of RA and its metabolites was significantly decreased by interruption of the enterohepatic circulation. The percentage of dose excreted in the urine decreased with increasing dose.


Tetrahedron Letters | 1984

The chemical identification of the rice weevil and maize weevil aggregation pheromone

Norman R. Schmuff; Joel K. Phillips; Wendell E. Burkholder; Henry M. Fales; Chi-Wan Chen; Peter P. Roller; Michael Ma

Abstract (R*,S*)-4-methyl-s-hydroxy-3-heptanone is identified as the major component of the aggregation pheromone of the rice weevil ( sitophilus oryzae L.) and the maize weevil ( S. zeamais Motsch.).


Phytochemistry | 1979

Halogenated acetic and acrylic acids from the red alga Asparagopsis taxiformis

Frank X. Woolard; Richard E. Moore; Peter P. Roller

Abstract Nine halogenated acetic acids and nine halogenated acrylic acids have been identified in the aqueous extract of Hawaiian Asparagopsis taxiformis .


Biochemistry | 2008

Interaction of a Cyclic, Bivalent Smac Mimetic with the X-Linked Inhibitor of Apoptosis Protein.

Zaneta Nikolovska-Coleska; Jennifer L. Meagher; Sheng Jiang; Chao Yie Yang; Su Qiu; Peter P. Roller; Jeanne A. Stuckey; Shaomeng Wang

We have designed and synthesized a cyclic, bivalent Smac mimetic (compound 3) and characterized its interaction with the X-linked inhibitor of apoptosis protein (XIAP). Compound 3 binds to XIAP containing both BIR2 and BIR3 domains with a biphasic dose-response curve representing two binding sites with IC 50 values of 0.5 and 406 nM, respectively. Compound 3 binds to XIAPs containing the BIR3-only and BIR2-only domain with K i values of 4 nM and 4.4 microM, respectively. Gel filtration experiments using wild-type and mutated XIAPs showed that 3 forms a 1:2 stoichiometric complex with XIAP containing the BIR3-only domain. However, it forms a 1:1 stoichiometric complex with XIAP containing both BIR2 and BIR3 domains, and both BIR domains are involved in the binding. Compound 3 efficiently antagonizes inhibition of XIAP in a cell-free functional assay and is >200 times more potent than its corresponding monovalent compound 2. Determination of the crystal structure of 3 in complex with the XIAP BIR3 domain confirms that 3 induces homodimerization of the XIAP BIR3 domain and provides a structural basis for the cooperative binding of one molecule of compound 3 to two XIAP BIR3 molecules. On the basis of this crystal structure, a binding model of XIAP containing both BIR2 and BIR3 domains and 3 was constructed, which sheds light on the ability of 3 to relieve the inhibition of XIAP with not only caspase-9 but also caspase-3/-7. Compound 3 is cell-permeable, effectively activates caspases in whole cells, and potently inhibits cancer cell growth. Compound 3 is a useful biochemical and pharmacological tool for further elucidating the role of XIAP in regulation of apoptosis and represents a promising lead compound for the design of potent, cell-permeable Smac mimetics for cancer treatment.

Collaboration


Dive into the Peter P. Roller's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Terrence R. Burke

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Feng-Di T. Lung

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Krzysztof Krajewski

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Peng Li

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Larry K. Keefer

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Motoyoshi Nomizu

Tokyo University of Pharmacy and Life Sciences

View shared research outputs
Top Co-Authors

Avatar

Sheng Jiang

University of Michigan

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge